News & Analysis on Clinical Trial Services & Contract Research And Development
The industry in March saw new c-suite appointments at CRF Bracket, PCI Pharma Services, George Clinical, and Paragon Bioservices – as well as moves to boost medical device and DMPK services at Premier Research and Sygnature Discovery, respectively.
Abzena launches a developability assessment and optimization service to assist customers in selecting and developing lead candidates for manufacture.
Thermo Fisher’s $1.7bn acquisition bolsters its ‘already strong position’ in the cell and gene therapy market, with increased CDMO capabilities.